C3ai, INC Form 4 insider transactions

NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 532,832 shares of Class A Common Stock in mid-December 2025 through a pre-arranged Rule 10b5-1 trading plan.
NYSE
C3.ai Director John E. Hyten sold 2,500 shares of Class A Common Stock for $14.65 per share as part of a pre-arranged Rule 10b5-1 plan.
NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NYSE
C3.ai director Michael Wayne Clayville was granted 34,091 stock options with a $15.92 exercise price, vesting over two years.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported significant equity transactions, including RSU conversions, new equity grants, and a tax-related share sale.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported the vesting and subsequent sale of shares for tax obligations, along with gift transfers, as detailed in a recent Form 4 filing.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 543,706 shares of Class A Common Stock for a weighted-average price of $15.24 per share, executed under a Rule 10b5-1 trading plan.
NYSE
C3.ai Executive Chairman Thomas Siebel reported the vesting of RSUs, subsequent sale for tax obligations, and a gift of shares, alongside changes in indirect holdings.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 554,802 shares of Class A Common Stock for approximately $10.4 million, executed under a pre-arranged 10b5-1 trading plan.
NYSE
C3.ai Director Stephen Ward Jr. was granted 30,264 stock options with an exercise price of $19.16, vesting over two years based on board meeting attendance.
NYSE
C3.ai Director KR Sridhar was granted 28,628 stock options with a $19.16 exercise price, vesting over two years tied to board meeting attendance.
NYSE
C3.ai Director D. Bruce Sewell received 30,264 stock options with a $19.16 exercise price, vesting over two years contingent on board meeting attendance.
NYSE
C3.ai Director Alan S. Murray was granted 28,628 stock options with an exercise price of $19.16, vesting over two years.
NYSE
C3.ai Director Condoleezza Rice exercised stock options and received a new grant of options, increasing her beneficial ownership.
NYSE
C3.ai, Inc. director Michael G. McCaffery was granted 32,309 stock options with an exercise price of $19.16.
NYSE
C3.ai Director Jim H. Snabe was granted 28,628 stock options with an exercise price of $19.16, vesting over two years contingent on board service and meeting attendance.
NYSE
C3.ai Director John E. Hyten was granted 28,628 stock options with an exercise price of $19.16, vesting quarterly over two years contingent on board meeting attendance.
NYSE
C3.ai Director Richard C. Levin was granted 28,628 stock options with an exercise price of $19.16, vesting over two years contingent on board meeting attendance.
NYSE
C3.ai's EVP & Chief Commercial Officer, Robert David Schilling, reported the acquisition of vested Restricted Stock Units and subsequent sales of Class A Common Stock.
NYSE
C3.ai's CEO, Stephen Bradley Ehikian, was granted over 2.4 million shares in Restricted Stock Units and stock options, aligning his incentives with long-term company performance.
NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NYSE
C3.ai Executive Chairman Thomas M. Siebel sold 566,125 shares of Class A Common Stock for a weighted-average price of $17.23 per share, totaling approximately $9.75 million, under a pre-arranged 10b5-1 trading plan.
NYSE
Thomas Siebel, Executive Chairman of C3.ai, reported the vesting of restricted stock units, a sale for tax obligations, and transfers of Class A Common Stock.
NYSE
C3.ai Executive Chairman Thomas M. Siebel reported the vesting of 32,736 RSUs, a sale of 17,200 shares for tax obligations, and a transfer of 15,536 shares.
NYSE
C3.ai CEO Thomas M. Siebel sold 577,678 shares of Class A Common Stock for approximately $9.69 million through a pre-arranged 10b5-1 trading plan.
NYSE
C3.ai CEO Thomas Siebel reported planned vesting of equity awards, subsequent tax-related share sales, and a gift transfer of Class A Common Stock.
NYSE
C3.ai CEO and 10% owner Thomas Siebel sold a total of 589,468 shares of Class A Common Stock on July 18, 2025, through a pre-established Rule 10b5-1 trading plan.
NYSE
C3.ai, Inc. has granted 1,011,327 Restricted Stock Units (RSUs) to Robert David Schilling, Executive Vice President & Chief Commercial Officer, aligning his compensation with long-term company performance.
NYSE
C3.ai, Inc. Director Kenneth A. Goldman was granted 54,722 stock options with an exercise price of $24.72, vesting quarterly based on board meeting attendance.
NYSE
C3.ai's Chief Financial Officer, Hitesh Lath, reported the vesting of Restricted Stock Units and subsequent sales of Class A Common Stock, including shares withheld for tax obligations and sales under a pre-established 10b5-1 trading plan.